Option Exercise Fee. In the event Biogen Idec elects to exercise the Option, it shall pay to AVEO a non-creditable, non-refundable option exercise fee of [**] U.S. dollars ($[**]) (the “Option Exercise Fee”) on or before the end of the Option Exercise Period.
Appears in 3 contracts
Samples: Option and License Agreement, Option and License Agreement (Aveo Pharmaceuticals Inc), Option and License Agreement (Aveo Pharmaceuticals Inc)
Option Exercise Fee. In the event Biogen Idec elects to exercise the Option, it shall pay to AVEO a non-creditable, non-refundable option exercise fee of [**] five million U.S. dollars ($[**]5,000,000) (the “Option Exercise Fee”) on or before the end of the Option Exercise Period.
Appears in 1 contract
Samples: Option and License Agreement (Aveo Pharmaceuticals, Inc.)
